1st Jul 2008 07:00
|
For immediate release |
1 July 2008 |
ALLIANCE PHARMA PLC
("Alliance Pharma" or "the Company")
Tax Credit Claims
Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announces that it is making Research & Development Tax Credit claims in respect of the 2006 and 2007 financial years, which could result in cash payments to the Company from HM Revenue & Customs of around £0.7m. These tax credit cash payments are likely to have a positive impact on the Company's reported profits in 2008. Neither claim has yet been finally agreed with HM Revenue and Customs, but Alliance Pharma has received £440,000 cash in respect of the claim for 2006.
The Company will provide a pre-close trading update in early July ahead of the announcement of its interim results for the six months ended 30 June 2008, which is scheduled for 10 September 2008.
For further information:
|
Alliance Pharma plc |
+ 44 (0) 1249 466966 |
|
John Dawson, Chief Executive |
|
|
Richard Wright, Finance Director |
|
|
www.alliancepharma.co.uk |
|
|
Buchanan Communications |
+ 44 (0) 20 7466 5000 |
|
Mark Court / Rebecca Skye Dietrich |
|
|
Numis Securities |
+ 44 (0) 20 7260 1000 |
|
David Poutney / Michael Meade / Brent Nabbs |
Related Shares:
Alliance Pharma